Skip to main content

GW Pharma Produces Prescription Cannabinoid Medicine

by CNBC



Justin Gover, managing director of GW Pharmaceuticals, told CNBC, "we have developed a product called Sativex, it is derived from two standardised extracts of specific plant types of Cannabis." http://video.cnbc.com/gallery/?video=3000060662

Mr. Justin Gover, BSc, MBA has been Managing Director of GW Pharmaceuticals PLC at GW Research Ltd since January 1999 and serves as its Chief Executive Officer. Mr. Gover is responsible for managing GW Pharmaceuticals's operations, equity financing and business development activities. Mr. Gover has 13 years' of experience in the biotech industry. Previously, he served as the Head of Corporate Affairs at Ethical Holdings plc, where he was responsible for strategic corporate activities, including mergers and acquisitions, equity financing and investor relations. He serves as an Executive Director at GW Pharmaceuticals PLC. He served as a Member of the Advisory Committee of Dawn Capital. Mr. Gover holds an MBA degree from the INSEAD business school in France. http://investing.businessweek.com/research/stocks/people/person.asp?personId=8421094&ticker=GWP:LN


Producer CNBC
Language English

Reviews

There are no reviews yet. Be the first one to write a review.
In Collection
Community Video
Uploaded by
qnbs7
on 7/1/2014
Views
8
Favorites
1
PEOPLE ALSO FOUND
Community Video
by EssiacHempLaetrile
26
0
0
Community Video
by James Barrat
13
0
0
Community Video
by Patients Out of Time
73
0
0
Community Video
by David Triplett
43
0
0
Community Video
by Jacob Appelbaum
10
0
0
Community Video
by American Voice Radio
408
0
0